Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q2 2022 vs. Q1 2022
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 7.51M | 7.73M | +220.7K (+2.9%) |
| Value | $2.83M | $767.0K | −$2.07M (−72.9%) |
New holders (3)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Arena Investors LP | 333,333 | $30.0K | 0.01% |
| Bank of Montreal | 12,500 | $1.00K | 0.00% |
| Clear Street LLC | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Apollo Management Holdings, L.P. | 967,726 | $348.0K |
| Governors Lane LP | 200,000 | $67.0K |
| Cohen & Co Financial Management, LLC | 69,847 | $25.0K |
| Susquehanna International Group, LLP | 11,742 | $4.00K |